Skip to main content
Top
Published in: Health Research Policy and Systems 1/2015

Open Access 01-12-2016 | Research

The 10 largest public and philanthropic funders of health research in the world: what they fund and how they distribute their funds

Authors: Roderik F. Viergever, Thom C. C. Hendriks

Published in: Health Research Policy and Systems | Issue 1/2015

Login to get access

Abstract

Background

Little is known about who the main public and philanthropic funders of health research are globally, what they fund and how they decide what gets funded. This study aims to identify the 10 largest public and philanthropic health research funding organizations in the world, to report on what they fund, and on how they distribute their funds.

Methods

The world’s key health research funding organizations were identified through a search strategy aimed at identifying different types of funding organizations. Organizations were ranked by their reported total annual health research expenditures. For the 10 largest funding organizations, data were collected on (1) funding amounts allocated towards 20 health areas, and (2) schemes employed for distributing funding (intramural/extramural, project/‘people’/organizational and targeted/untargeted funding). Data collection consisted of a review of reports and websites and interviews with representatives of funding organizations. Data collection was challenging; data were often not reported or reported using different classification systems.

Results

Overall, 55 key health research funding organizations were identified. The 10 largest funding organizations together funded research for $37.1 billion, constituting 40% of all public and philanthropic health research spending globally. The largest funder was the United States National Institutes of Health ($26.1 billion), followed by the European Commission ($3.7 billion), and the United Kingdom Medical Research Council ($1.3 billion). The largest philanthropic funder was the Wellcome Trust ($909.1 million), the largest funder of health research through official development assistance was USAID ($186.4 million), and the largest multilateral funder was the World Health Organization ($135.0 million). Funding distribution mechanisms and funding patterns varied substantially between the 10 largest funders.

Conclusions

There is a need for increased transparency about who the main funders of health research are globally, what they fund and how they decide on what gets funded, and for improving the evidence base for various funding models. Data on organizations’ funding patterns and funding distribution mechanisms are often not available, and when they are, they are reported using different classification systems. To start increasing transparency in health research funding, we have established www.​healthresearchfu​nders.​org that lists health research funding organizations worldwide and their health research expenditures.
Appendix
Available only for authorised users
Literature
1.
go back to reference Røttingen J-A, Regmi S, Eide M, Young AJ, Viergever RF, Årdal C, et al. Mapping available health R&D data: what’s there, what’s missing and what role for a Global Observatory. Lancet. 2013;382:1286–307.CrossRefPubMed Røttingen J-A, Regmi S, Eide M, Young AJ, Viergever RF, Årdal C, et al. Mapping available health R&D data: what’s there, what’s missing and what role for a Global Observatory. Lancet. 2013;382:1286–307.CrossRefPubMed
2.
go back to reference Viergever RF. The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions. Glob Health Action. 2013;6:22450.PubMed Viergever RF. The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions. Glob Health Action. 2013;6:22450.PubMed
3.
go back to reference Power E. Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect. 2006;12 Suppl 5:25–34.CrossRefPubMed Power E. Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect. 2006;12 Suppl 5:25–34.CrossRefPubMed
5.
go back to reference Head MG, Fitchett JR, Cooke MK, Wurie FB, Atun R, Hayward AC, et al. Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997–2010. J Antimicrob Chemother. 2014;69:548–54.CrossRefPubMed Head MG, Fitchett JR, Cooke MK, Wurie FB, Atun R, Hayward AC, et al. Systematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997–2010. J Antimicrob Chemother. 2014;69:548–54.CrossRefPubMed
6.
go back to reference Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156–65.CrossRefPubMed Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156–65.CrossRefPubMed
8.
go back to reference Terry RF, Allen L, Gardner C, Guzman J, Moran M, Viergever RF. Mapping global health research investments, time for new thinking – A Babel Fish for research data. Health Res Policy Syst. 2012;10:28.CrossRefPubMedPubMedCentral Terry RF, Allen L, Gardner C, Guzman J, Moran M, Viergever RF. Mapping global health research investments, time for new thinking – A Babel Fish for research data. Health Res Policy Syst. 2012;10:28.CrossRefPubMedPubMedCentral
11.
12.
go back to reference World Health Summit. Workshop: global health research & development: mapping funding flows – working towards a common approach. Geneva: WHO; 2014. World Health Summit. Workshop: global health research & development: mapping funding flows – working towards a common approach. Geneva: WHO; 2014.
13.
go back to reference Gillum LA, Gouveia C, Dorsey ER, Pletcher M, Mathers CD, McCulloch CE, et al. NIH disease funding levels and burden of disease. PLoS One. 2011;6:e16837.CrossRefPubMedPubMedCentral Gillum LA, Gouveia C, Dorsey ER, Pletcher M, Mathers CD, McCulloch CE, et al. NIH disease funding levels and burden of disease. PLoS One. 2011;6:e16837.CrossRefPubMedPubMedCentral
14.
go back to reference What has the Gates Foundation done for global health? Lancet. 2009;373:1577. What has the Gates Foundation done for global health? Lancet. 2009;373:1577.
15.
go back to reference Matthews KR, Ho V. The grand impact of the Gates Foundation. Sixty billion dollars and one famous person can affect the spending and research focus of public agencies. EMBO Rep. 2008;9:409–12.CrossRefPubMedPubMedCentral Matthews KR, Ho V. The grand impact of the Gates Foundation. Sixty billion dollars and one famous person can affect the spending and research focus of public agencies. EMBO Rep. 2008;9:409–12.CrossRefPubMedPubMedCentral
16.
go back to reference World Health Organization. WHO informal workshop – monitoring financial flows in support of health research & development. Geneva: WHO; 2013. World Health Organization. WHO informal workshop – monitoring financial flows in support of health research & development. Geneva: WHO; 2013.
17.
go back to reference Young AJ, Terry RF, Røttingen J-A, Viergever RF. Global biomedical R&D expenditures. N Engl J Med. 2014;370:2451.CrossRefPubMed Young AJ, Terry RF, Røttingen J-A, Viergever RF. Global biomedical R&D expenditures. N Engl J Med. 2014;370:2451.CrossRefPubMed
18.
go back to reference Chakma J, Sun GH, Steinberg JD, Sammut SM, Jagsi R. Asia’s ascent--global trends in biomedical R&D expenditures. N Engl J Med. 2014;370:3–6.CrossRefPubMed Chakma J, Sun GH, Steinberg JD, Sammut SM, Jagsi R. Asia’s ascent--global trends in biomedical R&D expenditures. N Engl J Med. 2014;370:3–6.CrossRefPubMed
19.
go back to reference Sun GH, Steinberg JD, Jagsi R. The calculus of national medical research policy--the United States versus Asia. N Engl J Med. 2012;367:687–90.CrossRefPubMed Sun GH, Steinberg JD, Jagsi R. The calculus of national medical research policy--the United States versus Asia. N Engl J Med. 2012;367:687–90.CrossRefPubMed
20.
go back to reference Young AJ, Terry RF, Røttingen J-A, Viergever RF. Global trends in health research and development R&D expenditures – the challenge of making reliable estimates for international comparison. Health Res Policy Syst. 2015;13. Young AJ, Terry RF, Røttingen J-A, Viergever RF. Global trends in health research and development R&D expenditures – the challenge of making reliable estimates for international comparison. Health Res Policy Syst. 2015;13.
21.
go back to reference Myers ER, Alciati MH, Ahlport KN, Sung NS. Similarities and differences in philanthropic and federal support for medical research in the United States: an analysis of funding by nonprofits in 2006–2008. Acad Med. 2012;87:1574–81.CrossRefPubMed Myers ER, Alciati MH, Ahlport KN, Sung NS. Similarities and differences in philanthropic and federal support for medical research in the United States: an analysis of funding by nonprofits in 2006–2008. Acad Med. 2012;87:1574–81.CrossRefPubMed
23.
go back to reference Braun D. Structure and dynamics of health research and public funding: an international institutional comparison. Dordrecht: Kluwer Academic Publishers; 1994. Braun D. Structure and dynamics of health research and public funding: an international institutional comparison. Dordrecht: Kluwer Academic Publishers; 1994.
24.
go back to reference UK Clinical Research Collaboration. UK health research analysis 2009/2010. London: UKCRC; 2010. UK Clinical Research Collaboration. UK health research analysis 2009/2010. London: UKCRC; 2010.
25.
go back to reference Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Atun R. UK investments in global infectious disease research 1997–2010: a case study. Lancet Infect Dis. 2013;2013(13):55–64.CrossRef Head MG, Fitchett JR, Cooke MK, Wurie FB, Hayward AC, Atun R. UK investments in global infectious disease research 1997–2010: a case study. Lancet Infect Dis. 2013;2013(13):55–64.CrossRef
26.
go back to reference Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, White-Stellato Z, et al. Funding of US biomedical research, 2003–2008. JAMA. 2010;303:137–43.CrossRefPubMedPubMedCentral Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, White-Stellato Z, et al. Funding of US biomedical research, 2003–2008. JAMA. 2010;303:137–43.CrossRefPubMedPubMedCentral
27.
go back to reference Moran M, Guzman J, Henderson K, Liyanage R, Wu L, Chin E, et al. G-FINDER 2012 – neglected disease research & development: a five year review. Sydney: Policy Cures; 2012. Moran M, Guzman J, Henderson K, Liyanage R, Wu L, Chin E, et al. G-FINDER 2012 – neglected disease research & development: a five year review. Sydney: Policy Cures; 2012.
28.
go back to reference Frick M, Jiménez-Levi E. Tuberculosis Research and Development. Report on tuberculosis research funding trends, 2005–2012. New York: Treatment Action Group; 2013. Frick M, Jiménez-Levi E. Tuberculosis Research and Development. Report on tuberculosis research funding trends, 2005–2012. New York: Treatment Action Group; 2013.
29.
go back to reference Head MG, Fitchett JR, Cooke GS, Foster GR, Atun R. Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom. J Viral Hepat. 2015;22(3):230–7. doi:10.1111/jvh.12300.CrossRefPubMed Head MG, Fitchett JR, Cooke GS, Foster GR, Atun R. Systematic analysis of funding awarded for viral hepatitis-related research to institutions in the United Kingdom. J Viral Hepat. 2015;22(3):230–7. doi:10.​1111/​jvh.​12300.CrossRefPubMed
31.
go back to reference Saving Lives through Research: Annual Report and Accounts 2012/13. London: Cancer Research UK; 2013. Saving Lives through Research: Annual Report and Accounts 2012/13. London: Cancer Research UK; 2013.
36.
go back to reference Kaiser J. Funding. NIH institute considers broad shift to “people” awards. Science. 2014;345:366–7.CrossRefPubMed Kaiser J. Funding. NIH institute considers broad shift to “people” awards. Science. 2014;345:366–7.CrossRefPubMed
37.
go back to reference Callahan D. Shaping biomedical research priorities: the case of the National Institutes of Health. Health Care Anal. 1999;7:115–29.CrossRefPubMed Callahan D. Shaping biomedical research priorities: the case of the National Institutes of Health. Health Care Anal. 1999;7:115–29.CrossRefPubMed
38.
39.
go back to reference Research funding needs overhaul. Science (80-) 2014, 345:122. Research funding needs overhaul. Science (80-) 2014, 345:122.
40.
go back to reference Banzi R, Moja L, Pistotti V, Facchini A, Liberati A. Conceptual frameworks and empirical approaches used to assess the impact of health research: an overview of reviews. Health Res Policy Syst. 2011;9:26.CrossRefPubMedPubMedCentral Banzi R, Moja L, Pistotti V, Facchini A, Liberati A. Conceptual frameworks and empirical approaches used to assess the impact of health research: an overview of reviews. Health Res Policy Syst. 2011;9:26.CrossRefPubMedPubMedCentral
41.
go back to reference Lal B, Wilson A, Jonas S, Lee E, Richards A, Peña V. An outcome evaluation of the national institutes of health (NIH) Director’s pioneer award (NDPA) program, FY 2004–2006. Washington: Ida Science & Technology Policy Institute; 2012. Lal B, Wilson A, Jonas S, Lee E, Richards A, Peña V. An outcome evaluation of the national institutes of health (NIH) Director’s pioneer award (NDPA) program, FY 2004–2006. Washington: Ida Science & Technology Policy Institute; 2012.
42.
go back to reference Collins FS, Wilder EL, Zerhouni E. NIH roadmap/common fund at 10 years. Science. 2014;345:274–6.CrossRefPubMed Collins FS, Wilder EL, Zerhouni E. NIH roadmap/common fund at 10 years. Science. 2014;345:274–6.CrossRefPubMed
43.
go back to reference Azoulay P, Graff Zivin JS, Manso G. Incentives and creativity: evidence from the academic life sciences. RAND J Econ. 2011;42:527–54.CrossRef Azoulay P, Graff Zivin JS, Manso G. Incentives and creativity: evidence from the academic life sciences. RAND J Econ. 2011;42:527–54.CrossRef
44.
go back to reference Viergever RF, Olifson S, Ghaffar A, Terry RF. A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst. 2010;8:36.CrossRefPubMedPubMedCentral Viergever RF, Olifson S, Ghaffar A, Terry RF. A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst. 2010;8:36.CrossRefPubMedPubMedCentral
47.
go back to reference Viergever RF, Hendriks TCC. Targeted public funding for health research in the Netherlands. Ned Tijdschr Geneeskd. 2014;159:A8174.PubMed Viergever RF, Hendriks TCC. Targeted public funding for health research in the Netherlands. Ned Tijdschr Geneeskd. 2014;159:A8174.PubMed
48.
go back to reference Collins F, Beaudet A, Draghia-Akli R, Gruss P, Savill J, Syrota A, et al. A database on global health research in Africa. Lancet Glob Heal. 2013;1:e64–5.CrossRef Collins F, Beaudet A, Draghia-Akli R, Gruss P, Savill J, Syrota A, et al. A database on global health research in Africa. Lancet Glob Heal. 2013;1:e64–5.CrossRef
49.
go back to reference Rani M, Bekedam H, Buckley BS. Improving health research governance and management in the Western Pacific: a WHO expert consultation. J Evid Based Med. 2011;4:204–13.CrossRefPubMed Rani M, Bekedam H, Buckley BS. Improving health research governance and management in the Western Pacific: a WHO expert consultation. J Evid Based Med. 2011;4:204–13.CrossRefPubMed
55.
go back to reference Terry RF, van der Rijt T. Overview of research activities associated with the World Health Organization: results of a survey covering 2006/07. Health Res Policy Syst. 2010;8:25.CrossRefPubMedPubMedCentral Terry RF, van der Rijt T. Overview of research activities associated with the World Health Organization: results of a survey covering 2006/07. Health Res Policy Syst. 2010;8:25.CrossRefPubMedPubMedCentral
Metadata
Title
The 10 largest public and philanthropic funders of health research in the world: what they fund and how they distribute their funds
Authors
Roderik F. Viergever
Thom C. C. Hendriks
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Health Research Policy and Systems / Issue 1/2015
Electronic ISSN: 1478-4505
DOI
https://doi.org/10.1186/s12961-015-0074-z

Other articles of this Issue 1/2015

Health Research Policy and Systems 1/2015 Go to the issue